An injection is a method of delivering a substance into the body through a needle or other injection device. Experienced clinicians want injection designers to treat it not as a needle-and-syringe problem alone, but as a complete clinical procedure shaped by the patient, medication, workflow, and care setting. The World Health Organization (WHO) estimates that at least 16 billion injections are administered worldwide each year, making usability, safety, and reliability consequential at scale. Clinicians’ priorities include predictable dose delivery, needle safety, manageable injection force, clear feedback, compatibility with real-world conditions, and designs that fit clinical workflows without adding risk or burden.
Why clinicians prioritize the whole injection experience
A clinical injection is a sequence of linked actions: preparing the medicine, selecting and positioning the device, administering the dose, confirming completion, and disposing of the sharp. Each step can be affected by device design. A product may perform well in a bench test yet be difficult to use with gloves, during a busy clinic session, for a patient with limited dexterity, or in a home setting with little supervision.
WHO’s injection-safety guidance emphasizes that unsafe injections can transmit infections and cause harm through needlestick injuries or inappropriate reuse. Its 2016 estimate of 16 billion injections annually is a global scale indicator, not a count of any single device type or a current annual census. The implication for designers is clear: small usability failures can be repeated across many patients and care encounters.
Clinical usability and injection-device design
Clinical usability is the extent to which intended users can use a device safely and effectively for its intended purpose in the intended environment. The U.S. Food and Drug Administration (FDA) frames human-factors engineering as the study and application of how people interact with technology, with the goal of reducing use errors and minimizing harm. For injection designers, that means evaluating the complete task—not just whether the device delivers fluid under ideal conditions.
Relevant device categories include conventional syringes and needles, prefilled syringes, pen injectors, autoinjectors, and needle-free injection systems. Their clinical contexts differ, but they share design demands: consistent dose delivery, understandable operation, appropriate protection from sharps, and clear communication of device status.
Dose accuracy and dependable completion
Dose accuracy means that the device delivers the intended amount of medication reliably. Clinicians need designers to account for the full operating sequence, including priming where required, the user’s grip and angle, injection duration, and the possibility that a patient stops early. A device should make it apparent when the dose has been delivered and should not encourage users to remove it before completion.
FDA human-factors guidance calls for identifying critical tasks and evaluating whether users can perform them safely. For an injection device, a critical task might include selecting the correct dose, attaching a needle, unlocking an autoinjector, or holding the device in place until delivery is complete. Designers should validate these tasks with representative users and realistic scenarios, rather than relying only on engineering specifications or expert staff.
Injection force, time, and patient comfort
Injection force is the effort needed to operate a device and push medication through its delivery pathway. High or inconsistent force can be difficult for people with arthritis, reduced hand strength, tremor, or small hands; it can also make administration less comfortable for caregivers. The required force depends on factors such as formulation viscosity, needle dimensions, and device mechanics, so designers should test the intended medicine and device together.
Clinicians also care about how long a dose takes and whether a user can maintain a stable position throughout delivery. A longer administration time may be workable in a supervised setting but challenging for a patient self-injecting at home. Usability studies should therefore capture time, effort, discomfort, and incomplete injections—not just whether participants eventually succeed.
Feedback, labeling, and error prevention
Feedback is information that helps users understand what the device is doing and whether the injection is complete. It may be visual, audible, or tactile. Clinicians value feedback that is unmistakable but not easy to misinterpret: a click alone, for example, may indicate activation rather than completed delivery. Instructions, labels, and device signals should reinforce one another and remain understandable under stress or distraction.
The FDA’s human-factors approach emphasizes designing to reduce the likelihood and consequences of use-related errors. Designers can apply this principle by making the correct action obvious, preventing incompatible assembly where feasible, distinguishing dose settings clearly, and avoiding controls that are easily activated by accident. Testing should include people with varied experience, literacy, vision, dexterity, and familiarity with the product.
Safety, workflow, and the realities of care
Usability is inseparable from safety. Needlestick prevention, infection control, storage, and disposal all shape whether an injection device works well in practice. A design that is easy to use but leaves a sharp exposed, for example, does not meet clinicians’ broader needs. Conversely, a safety feature that is difficult to activate or obscures the injection sequence can introduce new use problems.
Needlestick prevention and sharps disposal
A safety-engineered injection device incorporates features intended to reduce accidental exposure to a needle, such as a shield or retraction mechanism. The U.S. Occupational Safety and Health Administration’s Bloodborne Pathogens Standard requires employers to consider and use appropriate engineering and work-practice controls to reduce occupational exposure. Designers should therefore consider when a safety feature activates, whether activation is intuitive, and whether it can be confirmed without placing fingers near the sharp.
Disposal is part of the device journey, not an afterthought. The U.S. Environmental Protection Agency advises that household sharps should be placed in an FDA-cleared sharps disposal container where available, or handled according to applicable local guidance. A device’s size, shape, and post-use state can affect whether it fits available containers and whether patients can transport and dispose of it safely. Clear, locally adaptable disposal instructions help close the loop.
Workflow fit across clinics and home care
Workflow fit means that a device can be incorporated into the real sequence of care without creating avoidable delays, extra steps, or ambiguity. In a clinic, clinicians may need to prepare multiple doses, document administration, and answer patient questions while managing interruptions. At home, users may need to store the product, recognize when it is ready, and administer it without immediate professional support.
The same device may serve nurses, physicians, pharmacists, caregivers, and patients, each with different levels of training. Designers should map each user’s tasks and handoffs, then test the product in settings that resemble actual use. The FDA’s guidance on applying human factors to medical devices supports this user-centered approach, including consideration of use environments and foreseeable interactions with other products or processes.
Storage, transport, and environmental conditions
An injection device must remain usable through its intended storage and transport conditions. Temperature limits, light exposure, packaging, and product handling can affect the medicine, device materials, or the user’s ability to identify a product. Designers should make storage requirements clear and assess whether packaging remains readable and protective after ordinary handling.
FDA labeling requirements and product-specific instructions establish the authoritative conditions for a particular medicine-device combination. Clinicians need those instructions to be easy to find and consistent across the carton, device, and patient materials. Where a product is intended for travel or self-administration, testing should include practical scenarios such as carrying it, opening packaging, and distinguishing it from other medications.
Inclusive design and clinical validation
Inclusive injection design accounts for differences in bodies, abilities, experience, language, and care circumstances. A device that works for a trained clinician with strong vision and dexterity may not work equally well for an older adult, a person with impaired hand function, or a caregiver administering a first dose. Clinicians want these differences addressed before launch rather than treated as exceptions after problems appear.
Designing for varied users and abilities
Accessible design reduces unnecessary dependence on strength, fine motor control, vision, hearing, or complex instructions. Practical considerations include grip size and texture, readable type, strong contrast, clear orientation cues, and controls that can be operated without excessive force. Language and illustrations should support comprehension without assuming prior technical knowledge.
The FDA’s human-factors guidance recommends identifying intended users and considering their characteristics when assessing risks and designing validation studies. This is particularly important for products intended for self-injection. Testing should include the people expected to use the device, including relevant patient and caregiver groups, rather than relying exclusively on healthcare professionals.
Usability testing and real-world evidence
Usability testing evaluates whether representative users can complete tasks safely and effectively. Formative studies, conducted during development, help reveal confusing steps early enough to redesign them. Summative human-factors validation assesses whether the final device and its labeling support safe use by intended users in representative conditions.
A strong validation plan examines use errors, close calls, task completion, time, and users’ understanding of device feedback. It should also investigate why an error occurred: a missed step may reflect unclear labeling, poor control placement, a misleading signal, or a mismatch between the device and the care environment. The FDA recommends risk-based human-factors work for medical devices, and ISO 14971 provides a framework for medical-device risk management. Together, these approaches help connect observed usability issues to design changes and residual-risk decisions.
What experienced clinicians want designers to do
Clinicians’ feedback is most useful when it is treated as evidence about tasks and context, not as a substitute for systematic testing. A request for a larger grip, clearer completion signal, or simpler preparation step points to an underlying need that can be explored with users and evaluated against safety and performance requirements.
- Observe injections in the settings where they will actually occur, including home use when relevant.
- Test the medicine and device as a combined system, especially when viscosity or administration time affects operation.
- Make dose selection, activation, completion, and post-use safety states unmistakable.
- Include intended patients, caregivers, and healthcare professionals in development and validation.
- Design sharps protection and disposal into the full product journey.
- Use field feedback and post-market information to identify recurring errors and opportunities for improvement.
A useful illustration is the difference between a successful demonstration and a successful routine. In a demonstration, a trained person may follow a sequence without distraction; during routine care, the user may be interrupted, nervous, or unfamiliar with a new package. Human-factors evaluation asks whether the device remains understandable and safe under foreseeable conditions, and whether its design helps users recover from mistakes before harm occurs.
Conclusion: design for the clinical moment
Experienced clinicians want injection designers to see clinical usability, dose delivery, safety, workflow fit, and inclusive validation as connected design requirements. WHO’s estimate of at least 16 billion injections a year underscores the scale of the opportunity: improvements that prevent confusion, incomplete doses, or sharps injuries can matter across many care settings.
The practical next step is to involve clinicians and intended users early, observe real tasks, test the complete medicine-device system, and use human-factors findings to refine the design before release. Further reading from the FDA, WHO, OSHA, and EPA can help teams translate these priorities into regulatory, safety, and disposal practices tailored to the product and setting.
Sources: World Health Organization, WHO best practices for injections and related procedures toolkit, 2010, https://iris.who.int/handle/10665/44298; U.S. Food and Drug Administration, Applying Human Factors and Usability Engineering to Medical Devices, 2016, https://www.fda.gov/regulatory-information/search-fda-guidance-documents/applying-human-factors-and-usability-engineering-medical-devices; U.S. Occupational Safety and Health Administration, Bloodborne Pathogens Standard, 29 CFR 1910.1030, https://www.osha.gov/laws-regs/regulations/standardnumber/1910/1910.1030; U.S. Environmental Protection Agency, Medical Waste, https://www.epa.gov/rcra/medical-waste; International Organization for Standardization, ISO 14971:2019 Medical devices—Application of risk management to medical devices, https://www.iso.org/standard/72704.html